Lactate dehydrogenase A in cancer: a promising target for diagnosis and therapy (Q26851585)

Shile Sheng

2

1 reference

Xiaoguang Sun

3

1 reference

Jianjun Liu

4

1 reference

Gang Huang

5

1 reference

language of work or name

1 reference

November 2013

1 reference

1 reference

65

1 reference

PubMed

issue

11

1 reference

PubMed

page(s)

904-10

1 reference

Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance

PubMed

cites work

1 reference

Metabolic reprogramming: a cancer hallmark even warburg did not anticipate

21 January 2018

1 reference

Glycolysis inhibition for anticancer treatment

21 January 2018

1 reference

Regulation of cancer cell metabolism

21 January 2018

1 reference

Discovery of N-hydroxyindole-based inhibitors of human lactate dehydrogenase isoform A (LDH-A) as starvation agents against cancer cells.

21 January 2018

1 reference

Hypoxia-inducible factor 1 and cancer pathogenesis

21 January 2018

1 reference

Sugar-free approaches to cancer cell killing

21 January 2018

1 reference

A systematic review of lactate dehydrogenase isoenzyme 1 and germ cell tumors

21 January 2018

1 reference

Lactate dehydrogenase-5 (LDH-5) expression in human gastric cancer: association with hypoxia-inducible factor (HIF-1alpha) pathway, angiogenic factors production and poor prognosis

21 January 2018

1 reference

M-LDH serves as a regulatory subunit of the cytosolic substrate-channelling complex in vivo

21 January 2018

1 reference

Anticancer targets in the glycolytic metabolism of tumors: a comprehensive review

21 January 2018

1 reference

Metabolic regulation by lactate.

21 January 2018

1 reference

Serum lactate dehydrogenase is prognostic for survival in patients with bone metastases from breast cancer: a retrospective analysis in bisphosphonate-treated patients

21 January 2018

1 reference

Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression

21 January 2018

1 reference

c-Myc target genes involved in cell growth, apoptosis, and metabolism

21 January 2018

1 reference

Emerging metabolic targets in cancer therapy

21 January 2018

1 reference

MYC-induced cancer cell energy metabolism and therapeutic opportunities

21 January 2018

1 reference

Roles of p53, MYC and HIF-1 in regulating glycolysis - the seventh hallmark of cancer

21 January 2018

1 reference

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

21 January 2018

1 reference

Upregulation of lactate dehydrogenase A by ErbB2 through heat shock factor 1 promotes breast cancer cell glycolysis and growth.

21 January 2018

1 reference

Pyruvate kinase M2 is a PHD3-stimulated coactivator for hypoxia-inducible factor 1

21 January 2018

1 reference

Pyruvate kinase M2 regulates glucose metabolism by functioning as a coactivator for hypoxia-inducible factor 1 in cancer cells

21 January 2018

1 reference

ERK1/2-dependent phosphorylation and nuclear translocation of PKM2 promotes the Warburg effect

21 January 2018

1 reference

LDH-A influences hypoxia-inducible factor 1α (HIF1 α) and is critical for growth of HT29 colon carcinoma cells in vivo.

21 January 2018

1 reference

c-Myc transactivation of LDH-A: implications for tumor metabolism and growth

21 January 2018

1 reference

AMPK is a negative regulator of the Warburg effect and suppresses tumor growth in vivo

21 January 2018

1 reference

LDH-A inhibition, a therapeutic strategy for treatment of hereditary leiomyomatosis and renal cell cancer

21 January 2018

1 reference

Expression profiling in progressive stages of fumarate-hydratase deficiency: the contribution of metabolic changes to tumorigenesis

21 January 2018

1 reference

PEO-PPO block copolymers for passive micellar targeting and overcoming multidrug resistance in cancer therapy.

21 January 2018

1 reference

Lactate dehydrogenase A is overexpressed in pancreatic cancer and promotes the growth of pancreatic cancer cells

21 January 2018

1 reference

LDHA is necessary for the tumorigenicity of esophageal squamous cell carcinoma

21 January 2018

1 reference

Knockdown of lactate dehydrogenase A suppresses tumor growth and metastasis of human hepatocellular carcinoma

21 January 2018

1 reference

Hypoxia-induced lactate dehydrogenase expression and tumor angiogenesis

21 January 2018

1 reference

Prognostic and predictive role of lactate dehydrogenase 5 expression in colorectal cancer patients treated with PTK787/ZK 222584 (vatalanib) antiangiogenic therapy

21 January 2018

1 reference

Serum lactate dehydrogenase predicts for overall survival benefit in patients with metastatic renal cell carcinoma treated with inhibition of mammalian target of rapamycin.

21 January 2018

1 reference

Efficacy of RAD001 (everolimus) and octreotide LAR in advanced low- to intermediate-grade neuroendocrine tumors: results of a phase II study

21 January 2018

1 reference

Serum lactate dehydrogenase levels and glycolysis significantly correlate with tumor VEGFA and VEGFR expression in metastatic CRC patients

21 January 2018

1 reference

Warburg effect in chemosensitivity: targeting lactate dehydrogenase-A re-sensitizes taxol-resistant cancer cells to taxol

21 January 2018

1 reference

Alterations of metabolic genes and metabolites in cancer

21 January 2018

1 reference

Inhibition of LDH-A by lentivirus-mediated small interfering RNA suppresses intestinal-type gastric cancer tumorigenicity through the downregulation of Oct4.

21 January 2018

1 reference

Inhibitors of lactate dehydrogenase isoforms and their therapeutic potentials

21 January 2018

1 reference

Lactate Dehydrogenase 5 Expression in Operable Colorectal Cancer: Strong Association With Survival and Activated Vascular Endothelial Growth Factor Pathway—A Report of the Tumour Angiogenesis Research Group

21 January 2018

1 reference

Lactate dehydrogenase as a prognostic factor for survival time of terminally ill cancer patients: a preliminary study

21 January 2018

1 reference